Logo image of EGLX

ENTHUSIAST GAMING HOLDINGS I (EGLX) Stock Fundamental Analysis

NASDAQ:EGLX - CA29385B1094 - Common Stock

0.25 USD
-0.03 (-11.97%)
Last: 10/27/2023, 8:12:22 PM
0.225 USD
-0.02 (-10%)
After Hours: 10/27/2023, 8:12:22 PM
Fundamental Rating

2

EGLX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 69 industry peers in the Interactive Media & Services industry. EGLX may be in some trouble as it scores bad on both profitability and health. EGLX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year EGLX has reported negative net income.
EGLX had a negative operating cash flow in the past year.
EGLX had negative earnings in each of the past 5 years.
In the past 5 years EGLX always reported negative operating cash flow.
EGLX Yearly Net Income VS EBIT VS OCF VS FCFEGLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 -20M -40M -60M

1.2 Ratios

EGLX has a Return On Assets of -22.77%. This is in the lower half of the industry: EGLX underperforms 77.61% of its industry peers.
With a Return On Equity value of -30.17%, EGLX is not doing good in the industry: 64.18% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -22.77%
ROE -30.17%
ROIC N/A
ROA(3y)-16%
ROA(5y)-41.15%
ROE(3y)-22.97%
ROE(5y)-95.05%
ROIC(3y)N/A
ROIC(5y)N/A
EGLX Yearly ROA, ROE, ROICEGLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 -100 -200 -300

1.3 Margins

EGLX has a Gross Margin of 33.61%. This is in the lower half of the industry: EGLX underperforms 71.64% of its industry peers.
In the last couple of years the Gross Margin of EGLX has grown nicely.
EGLX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.63%
GM growth 5Y15.77%
EGLX Yearly Profit, Operating, Gross MarginsEGLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 0 -200 -400 -600

1

2. Health

2.1 Basic Checks

EGLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EGLX has more shares outstanding
The debt/assets ratio for EGLX is higher compared to a year ago.
EGLX Yearly Shares OutstandingEGLX Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 50M 100M 150M
EGLX Yearly Total Debt VS Total AssetsEGLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 100M 200M 300M

2.2 Solvency

EGLX has an Altman-Z score of -0.47. This is a bad value and indicates that EGLX is not financially healthy and even has some risk of bankruptcy.
EGLX has a worse Altman-Z score (-0.47) than 68.66% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that EGLX is not too dependend on debt financing.
EGLX has a Debt to Equity ratio of 0.05. This is comparable to the rest of the industry: EGLX outperforms 49.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z -0.47
ROIC/WACCN/A
WACC9.36%
EGLX Yearly LT Debt VS Equity VS FCFEGLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 0.90 indicates that EGLX may have some problems paying its short term obligations.
EGLX has a worse Current ratio (0.90) than 85.07% of its industry peers.
EGLX has a Quick Ratio of 0.90. This is a bad value and indicates that EGLX is not financially healthy enough and could expect problems in meeting its short term obligations.
EGLX has a worse Quick ratio (0.90) than 85.07% of its industry peers.
Industry RankSector Rank
Current Ratio 0.9
Quick Ratio 0.9
EGLX Yearly Current Assets VS Current LiabilitesEGLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 20M 40M 60M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.52% over the past year.
EGLX shows a small growth in Revenue. In the last year, the Revenue has grown by 7.61%.
EGLX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 126.67% yearly.
EPS 1Y (TTM)15.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.71%
Revenue 1Y (TTM)7.61%
Revenue growth 3Y158.37%
Revenue growth 5Y126.67%
Sales Q2Q%-9.09%

3.2 Future

EGLX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.77% yearly.
The Revenue is expected to grow by 6.51% on average over the next years.
EPS Next Y42.95%
EPS Next 2Y29.93%
EPS Next 3Y24.77%
EPS Next 5YN/A
Revenue Next Year-7.9%
Revenue Next 2Y3.61%
Revenue Next 3Y6.51%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EGLX Yearly Revenue VS EstimatesEGLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
EGLX Yearly EPS VS EstimatesEGLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 -0.1 -0.2 -0.3 -0.4

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EGLX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EGLX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EGLX Price Earnings VS Forward Price EarningsEGLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EGLX Per share dataEGLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

EGLX's earnings are expected to grow with 24.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.93%
EPS Next 3Y24.77%

0

5. Dividend

5.1 Amount

EGLX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ENTHUSIAST GAMING HOLDINGS I

NASDAQ:EGLX (10/27/2023, 8:12:22 PM)

After market: 0.225 -0.02 (-10%)

0.25

-0.03 (-11.97%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)08-14 2023-08-14/amc
Earnings (Next)11-13 2023-11-13/amc
Inst Owners0%
Inst Owner Change-97.69%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap38.69M
Analysts84.62
Price Target2.41 (864%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-21.37%
Min EPS beat(2)-50.83%
Max EPS beat(2)8.09%
EPS beat(4)2
Avg EPS beat(4)-17.43%
Min EPS beat(4)-50.83%
Max EPS beat(4)9.7%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-11.88%
Min Revenue beat(2)-16.4%
Max Revenue beat(2)-7.35%
Revenue beat(4)0
Avg Revenue beat(4)-8.6%
Min Revenue beat(4)-16.4%
Max Revenue beat(4)-0.28%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.41%
PT rev (3m)-7.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-13.01%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.83%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.27
P/FCF N/A
P/OCF N/A
P/B 0.21
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.24
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0.94
BVpS1.17
TBVpS-0.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.77%
ROE -30.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.61%
FCFM N/A
ROA(3y)-16%
ROA(5y)-41.15%
ROE(3y)-22.97%
ROE(5y)-95.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.63%
GM growth 5Y15.77%
F-Score4
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.36%
Cap/Sales 0.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.9
Quick Ratio 0.9
Altman-Z -0.47
F-Score4
WACC9.36%
ROIC/WACCN/A
Cap/Depr(3y)0.1%
Cap/Depr(5y)6.78%
Cap/Sales(3y)0.01%
Cap/Sales(5y)0.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.71%
EPS Next Y42.95%
EPS Next 2Y29.93%
EPS Next 3Y24.77%
EPS Next 5YN/A
Revenue 1Y (TTM)7.61%
Revenue growth 3Y158.37%
Revenue growth 5Y126.67%
Sales Q2Q%-9.09%
Revenue Next Year-7.9%
Revenue Next 2Y3.61%
Revenue Next 3Y6.51%
Revenue Next 5YN/A
EBIT growth 1Y6.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year78.89%
EBIT Next 3Y33.17%
EBIT Next 5YN/A
FCF growth 1Y-23.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-22.97%
OCF growth 3YN/A
OCF growth 5YN/A